Drug Trial Radar · NCT05316155
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
235
Actual
Start
Apr 11, 2022
Primary completion
Mar 30, 2028
Study completion Jul 24, 2029
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Apr 7, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study in Part 1 (dose escalation) and in Part 2 (dose expansion) is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) and evaluate preliminary clinical efficacy. Part 3 (dose expansion) will confirm safety and preliminary clinical activity at the RP2D. Part 4 (RP2D expansion; MoonRISe-2) will assess the overall complete response (CR) in participants with intermediate-risk-non-muscle invasive bladder cancer (IR-NMIBC; means the cancer cells are only in the bladder's inner lining).
Conditions
- Non-Muscle Invasive Bladder Neoplasms
Interventions
Erdafitinib Intravesical Delivery SystemDrug
Erdafitinib intravesical delivery system will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Parts 1 to 3: Number of Participants with Adverse Events (AEs)Time frame: Up to approximately 7 years 4 months
- Parts 1 to 3: Number of Participants with AEs by SeverityTime frame: Up to approximately 7 years 4 months
- Part 1: Number of Participants with Dose-limiting Toxicity (DLT)Time frame: Up to 28 days
- Part 4: Overall Complete Response (CR) in Participants with Intermediate Risk-Non-Muscle Invasive Bladder Cancer (IR-NMIBC)Time frame: Up to approximately 7 years 4 months
Locations
59 sites in 8 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham - The Kirklin Clinic
Birmingham, Alabama
University of Southern California
Los Angeles, California
Urology Associates of Denver
Lone Tree, Colorado
Urological Research Network
Hialeah, Florida
Advanced Urology Institute
Largo, Florida
Advent Health Orlando
Orlando, Florida
Advanced Urology Institute 1
Oxford, Florida
H Lee Moffitt Cancer Center
Tampa, Florida
Northwestern University
Chicago, Illinois
Associated Urological Specialists
Chicago Ridge, Illinois
Urology of Indiana
Greenwood, Indiana
Urologic Specialists of Northwest Indiana
Merrillville, Indiana
University of Kentucky
Lexington, Kentucky
Southern Urology LLC
Lafayette, Louisiana
Greater Boston Urology
Plymouth, Massachusetts
Specialty Clinical Research of St Louis
St Louis, Missouri
Hackensack University Medical Center Urology
Hackensack, New Jersey
Associated Medical Professionals
Syracuse, New York
Levine Cancer Institute, Carolinas HealthCare System
Charlotte, North Carolina
Central Ohio Urology Group
Gahanna, Ohio
Carolina Urologic Research Center
Myrtle Beach, South Carolina
Low Country Urology Clinics
North Charleston, South Carolina
Urology Associates
Nashville, Tennessee
Urology Austin
Austin, Texas
Urology San Antonio Research
San Antonio, Texas
Vancouver Prostate Centre Diamond Health Care Centre
Vancouver, British Columbia, Canada
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
St Josephs Healthcare Hamilton
Hamilton, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Universitatsklinikum Carl Gustav Carus Dresden
Dresden, Germany
Urologicum Duisburg
Duisburg, Germany
Universitatsklinikum Frankfurt
Frankfurt am Main, Germany
Marien hospital Herne
Herne, Germany
Urologie Neandertal Praxis Mettmann
Mettmann, Germany
Universitatsklinikum Munster
Münster, Germany
Universitaetsklinikum Ulm
Ulm, Germany
Rambam Medical Center
Haifa, Israel
Carmel Medical Center
Haifa, Israel
Rabin Medical Center
Petah Tikva, Israel
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Showing 40 of 59 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.